Liaoning Kelong Fine Chemical,Inc. (SHE:300405)
China · Delayed Price · Currency is CNY 7.06
+0.03 (0.43%)
Feb 13, 2026, 3:04 PM CST
SHE:300405 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 565.24 | 629.13 | 555.83 | 775.95 | 1,082 | 922.4 |
Other Revenue | 2.7 | 2.7 | 2.36 | 4.3 | 6.81 | 6.41 |
| 567.95 | 631.83 | 558.2 | 780.25 | 1,089 | 928.8 | |
Revenue Growth (YoY) | -5.69% | 13.19% | -28.46% | -28.34% | 17.22% | -1.58% |
Cost of Revenue | 530.51 | 589.64 | 535 | 773.96 | 935.24 | 813.45 |
Gross Profit | 37.44 | 42.19 | 23.2 | 6.29 | 153.53 | 115.36 |
Selling, General & Admin | 53.73 | 51.56 | 64.46 | 70.73 | 75.43 | 97.26 |
Research & Development | 7.21 | 9.03 | 9.09 | 13.09 | 10.59 | 22.01 |
Other Operating Expenses | 13.9 | 6.42 | 5.59 | 5.97 | 8.12 | 6.66 |
Operating Expenses | 79.71 | 73.7 | 105.47 | 150.26 | 113.16 | 140.39 |
Operating Income | -42.27 | -31.51 | -82.27 | -143.97 | 40.36 | -25.04 |
Interest Expense | -21.01 | -28.72 | -27.29 | -27.72 | -31.82 | -34.21 |
Interest & Investment Income | 1.36 | 1.6 | 3.2 | 21.66 | 3.02 | 3.09 |
Currency Exchange Gain (Loss) | 0.49 | 0.49 | 0.25 | 1.46 | -0.65 | -4.94 |
Other Non Operating Income (Expenses) | -9.23 | 0.09 | -1.84 | -8.16 | -1.74 | 0.74 |
EBT Excluding Unusual Items | -70.66 | -58.05 | -107.96 | -156.73 | 9.17 | -60.36 |
Impairment of Goodwill | - | - | - | -0.2 | - | - |
Gain (Loss) on Sale of Investments | -1.88 | -0.96 | -0.69 | - | -4.12 | -5.25 |
Gain (Loss) on Sale of Assets | 0.34 | 0.37 | 0.03 | 0.03 | 0 | 0.35 |
Asset Writedown | -16.52 | -16.52 | -3.59 | -2.05 | -0.26 | -26.45 |
Other Unusual Items | 23.67 | 19.58 | 18.03 | 6.88 | 3.25 | 16.59 |
Pretax Income | -65.05 | -55.59 | -94.17 | -152.08 | 8.04 | -75.12 |
Income Tax Expense | -6.27 | -5.78 | 6.13 | -33.35 | -7.37 | -13.52 |
Earnings From Continuing Operations | -58.78 | -49.81 | -100.3 | -118.73 | 15.41 | -61.59 |
Minority Interest in Earnings | -0 | -0.02 | 0.07 | -0.03 | -3.49 | 0.86 |
Net Income | -58.78 | -49.83 | -100.23 | -118.75 | 11.92 | -60.74 |
Net Income to Common | -58.78 | -49.83 | -100.23 | -118.75 | 11.92 | -60.74 |
Shares Outstanding (Basic) | 284 | 284 | 288 | 289 | 289 | 289 |
Shares Outstanding (Diluted) | 284 | 284 | 288 | 289 | 289 | 289 |
Shares Change (YoY) | -0.07% | -1.24% | -0.41% | -0.07% | 0.07% | -2.04% |
EPS (Basic) | -0.21 | -0.18 | -0.35 | -0.41 | 0.04 | -0.21 |
EPS (Diluted) | -0.21 | -0.18 | -0.35 | -0.41 | 0.04 | -0.21 |
Free Cash Flow | 13.79 | 19.09 | -15.47 | -121.89 | -4.83 | -31.89 |
Free Cash Flow Per Share | 0.05 | 0.07 | -0.05 | -0.42 | -0.02 | -0.11 |
Dividend Per Share | - | - | - | - | 0.023 | - |
Gross Margin | 6.59% | 6.68% | 4.15% | 0.81% | 14.10% | 12.42% |
Operating Margin | -7.44% | -4.99% | -14.74% | -18.45% | 3.71% | -2.70% |
Profit Margin | -10.35% | -7.89% | -17.96% | -15.22% | 1.09% | -6.54% |
Free Cash Flow Margin | 2.43% | 3.02% | -2.77% | -15.62% | -0.44% | -3.43% |
EBITDA | -7.52 | 6.99 | -38.79 | -95.97 | 85.34 | 21.2 |
EBITDA Margin | -1.32% | 1.11% | -6.95% | -12.30% | 7.84% | 2.28% |
D&A For EBITDA | 34.75 | 38.5 | 43.49 | 48 | 44.98 | 46.24 |
EBIT | -42.27 | -31.51 | -82.27 | -143.97 | 40.36 | -25.04 |
EBIT Margin | -7.44% | -4.99% | -14.74% | -18.45% | 3.71% | -2.70% |
Revenue as Reported | 568.56 | 632.2 | 558.45 | 781.23 | 1,089 | 929.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.